Products

What will AGI do for Atovaquone?

This classification denotes an antimalarial and anti-infective agent with the molecular formula C22H19ClO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y883P1Z2LT, chemically known as 1,4-naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy- but generally known as atovaquone, which bears US NIH Compound Identifier 74989. Atovaquone most often comes in base form and is sometimes combined with proguanil. European Medicines Agency schedules Atovaquone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05602MIG. The term ATOVAQUONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules atovaquone in its Anatomical Therapeutic Chemical (ATC) Classification. ATOVAQUONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule atovaquone under HS 29147000 and SITC 51629. As of Q4 2014, ATOVAQUONE remains the US FDA Preferred Term for this commodity. Atovaquone bears US NLM identifiers UMLS ID C0165603 and NCI Concept Code C28838. SMILES: CLC1CCC(C2CCC(CC2)C2=C(O)C3C(C(=O)C2=O)CCCC3)CC1.